Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

WAKEFIELD, MA – November 2, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today receipt of written feedback from the U.S. Food and Drug Administration (FDA) that is in general agreement with the Company’s planned clinical trial for Brilacidin, a defensin-mimetic drug candidate, for the treatment of COVID-19. The FDA response completes the Pre-Investigational New Drug (Pre-IND) process.

http://www.ipharminc.com/press-release/2020/11/2/innovation-pharmaceuticals-receives-pre-ind-response-from-fda-on-covid-19-trial

Hopefully this helps.

Go Leo & IPIX!

Does anyone know if we have wait for approvals from anyone before beginning the clinical trials. I believe an assumed the sites were already chosen with the return response from the FDA on Pre-IND response.

Should response be construed as “acceptance “ that the clinical trial proceed without additional approvals?

Hoping for a quick results from the hospitals and doctors reviewing the identified patients.

Trying to accumulate more today.

GLTA.